June 2010 California Pertussis Update. Pertussis Background Pertussis is the most poorly controlled...
-
Upload
gloria-price -
Category
Documents
-
view
254 -
download
1
Transcript of June 2010 California Pertussis Update. Pertussis Background Pertussis is the most poorly controlled...
June 2010 California Pertussis Update
Pertussis Background
• Pertussis is the most poorly controlled vaccine-preventable disease Incidence increasing since the 1990s Cyclical: peaks every 2-5 years as numbers of
susceptible people increase enough to allow sustained transmission; last peak year 2005 with 25,616 U.S. cases, a 45 year high
• Adults are vulnerable to pertussis 27% of reported cases are among adults Pertussis immunity wanes 5 to 10 years after DTaP*
series (immunity from disease wanes in 15 years) ~25% of cough illness lasting >2 weeks is pertussis
• First pertussis vaccines (Tdap)† for adolescents and adults licensed in 2005; uptake suboptimal
*Diphtheria and tetanus toxoids and acellular pertussis vaccine†Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine
Typical Symptoms of Pertussis
• Three-stage bacterial illness (catarrhal, paroxysmal and convalescent) that lasts 4-12 weeks
• Typical symptoms paroxysmal cough lack of fever no systemic illness coryza; no pharyngitis posttussive vomiting posttussive whoop absolute lymphocytosis
• Adults with pertussis often report feeling as if they’re choking on something, sweating episodes
Pertussis in Young Infants
• Initially infant looks deceptively well; coryza, no fever, mild cough
• Leukocytosis with lymphocytosis• Apneic episodes• Seizures• Respiratory distress• Pneumonia• Adenovirus or RSV coinfection can confuse
picture
Pertussis hospitalizations in infants <1 year, by age in weeks – California, 2008
0
5
10
15
20
25
30
age in weeks
ho
sp
ita
liza
tio
ns
Pertussis resurgence since the 1990s
• Genetic changes in B. pertussis; greater virulence?
• Variable vaccine efficacy (acellular pertussis vaccines licensed in 1991 for 4th/5th doses; entire series in 1996)
• Waning of vaccine-induced immunity and lack of natural booster events
• General availability of better laboratory tests• Greater awareness of pertussis by clinicians
Number of reported pertussis cases by onset year ― California,
1913-2009
0
5,000
10,000
15,000
20,000
25,000
1913 1923 1933 1943 1953 1963 1973 1983 1993 2003
Num
ber
of r
epor
ted
case
s
Number of reported pertussis cases, by year, California, 1976-2009
0
500
1000
1500
2000
2500
3000
3500
1976 1981 1986 1991 1996 2001 2006
YearN
um
be
r o
f re
po
rte
d c
ases
Hospitalized Pertussis cases by age – California, 1998-2009
Number of pertussis cases, hospitalizations and deaths, by onset year
– California, 2003-2009
§2009 data provisional
2
3
1
3 3 3
8
0
500
1000
1500
2000
2500
3000
3500
2003 2004 2005 2006 2007 2008 2009§
year
cas
es/h
osp
ital
izat
ion
s
0
1
2
3
4
5
6
7
8
9
dea
ths
Cases*
Hospitalizations
Deaths
California Pertussis Cases - 2010• As of 6/15/2010, there have been 910 pertussis
cases reported in 2010, a 4-fold increase from the number of reported cases during the same time period in 2009; an additional 600 cases are under investigation
• From January through June of 2005 there were 1,261 pertussis cases; these data suggest the disease burden is at or above the levels seen in 2005, which was a 45 year high in cases
• Other states are reporting 2010 increases to CDC, but none reporting increases similar to those in California
• Possible differences in states with and without middle school Tdap vaccination requirement
Children's Hospital Central CaliforniaLaboratory Confirmed Cases of Pertussis (6/17/10)
1
4 4
7
17
1414
19
27
23
86
11
2
9
3
7
4 4 53
53
2 23
20
20
20
31
01 2
01 1
01 2
0
31
0 0 01 2
0
53
2
7
01 2 2
3 35
7
11
19
47
33
02468
101214161820222426283032343638404244464850
No
v-04
Dec
-04
Jan
-05
Feb
-05
Mar
-05
Ap
r-05
May
-05
Jun
-05
Jul-
05A
ug
-05
Sep
-05
Oct
-05
No
v-05
Dec
-05
Jan
-06
Feb
-06
Mar
-06
Ap
r-06
May
-06
Jun
-06
Jul-
06A
ug
-06
Sep
-06
Oct
-06
No
v-06
Dec
-06
Jan
-07
Feb
-07
Mar
-07
Ap
r-07
May
-07
Jun
-07
Jul-
07A
ug
-07
Sep
-07
Oct
-07
No
v-07
Dec
-07
Jan
-08
Feb
-08
Mar
-08
Ap
r-08
May
-08
Jun
-08
Jul-
08A
ug
-08
Sep
-08
Oct
-08
No
v-08
Dec
-08
Jan
-09
Feb
-09
Mar
-09
Ap
r-09
May
-09
Jun
-09
Jul-
09A
ug
-09
Sep
-09
Oct
-09
No
v-09
Dec
-09
Jan
-10
Feb
-10
Mar
-10
Ap
r-10
May
-10
Jun
-10
Month of Diagnosis
No
. of
Ca
se
s
0
50
100
150
200
250
month of report
case
s
2009
2010
X=2009 death (symptom onset)X=2010 death (symptom onset)
X
XXX
X
X
X
Epidemic curve of pertussis cases by month of report and deaths by month of onset– California, 2009-2010
X
California Pertussis Deaths• Five deaths in 2010 to date• All CA pertussis deaths (~3/year) since 1996,
except one, have been in infants <3 months of age; age at symptom onset ranged from 5 days – 8 weeks
• 80% Hispanic (50% of birth cohort Hispanic)• The mean WBC of fatal cases in 1998-2009 was
75,000 (range 15,000-148,000) Pertussis toxin elicits a dose-dependent leukocytosis
• Of those with known status, all had pulmonary HTN Increases in leukocyte mass can diminish blood flow by
increasing vascular resistance; however, pulmonary HTN is generally initiated and maintained by many factors
• Risk factor study being conducted
Age-specific pertussis rates by race/ethnicity -- California, 2010
0
5
10
15
20
25
30
35
40
<1 1-6 7-9 10-18 19-64 65+
age
ca
ses
per
10
0,0
00
White
Hispanic
API
Black
2008 Infant Pertussis Hospitalization Costs in California• In 2008, there were 222 hospitalizations in infants
<1 year of age with the diagnosis code for pertussis 96% were <4 months of age at admission Median length of stay 3.5 days (range 1—52 days) 2 deaths 73% Medi-Cal payer 63% Hispanic 22% White 5% Black 3% API
• Charge data is listed for 202 hospitalizations, of these: Mean total charge: $46,328 Median total charge: $18,966 Range $2,876--$798,748
Pertussis Mitigation• Promote the use of Tdap - particularly in those
who have contact with infants Free vaccine through 9/30/2010 for birth hospitals with
postpartum Tdap policies; encourage ED use of Tdap Work with payers re: Tdap reimbursement
• Clinician education CDPH Tdap recommendations Pertussis signs and symptoms Treatment recommendations for infants with severe
pertussis Accelerated DTaP schedule for infants
• Public education Vaccination/cocooning Pertussis signs and symptoms Keep ill people away from infants
Pertussis Transmission to Infants• Adults transmit pertussis to infants
Among 264 known source-cases:Almost 50% were parents, most often mothers51% were adults >19 years of age
Bisgard KM, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23(11):985-989.
Wendelboe AM, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26(4):293-299.
Pertussis incidence by age -- California, 2010
0
5
10
15
20
25
30
<1 1-6 7-9 10-18 19-64 65+
age group
case
s p
er 1
00,0
00
Cases and incidence of laboratory confirmed pertussis cases by age –
California, 2008
0
20
40
60
80
100
120
140
160
<1 1-9 10-17 18+
age group
ca
se
s
0
5
10
15
20
25
30
rate
pe
r 1
00
,00
0
cases
Incidence
0
2
4
6
8
10
12
14
16
2005 2006 2007 2008 2009 2010§
year
case
s p
er 1
00,0
00
1-6
7-10
11-18
19-64
65+
All ages
Pertussis incidence by age group (excluding infants)-- California, 2005-2010
Pertussis incidence by age group (excluding infants) – U.S. 2004-2008